As of 28 Aug 2026, Natco Pharma Ltd share price is ₹858.20. The stock opened at ₹858.20 and had closed at ₹863.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹789.30 and a high of ₹1,226.10. In terms of performance, Natco Pharma Ltd share price has decreased by 12.30% over the past six months and has decreased by 0.39% over the last year.
NATCOPHARM Charts
Natco Pharma Ltd Overview
About NATCOPHARM
Natco Pharma is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations.
Natco Pharma Ltd Historical Performance
Natco Pharma Ltd Fundamental Analysis
Natco Pharma Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 644.90 | 681.70 | 584.10 | 1,357.60 | 1,252.30 |
| EBITDA | 154.30 | 165.30 | 175.60 | 645.80 | 599.30 |
| Net Profit | 74.60 | 209.60 | 106.90 | 500.90 | 464.10 |
| EPS | 4.17 | 11.70 | 5.97 | 27.97 | 25.91 |
Natco Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 35.01 |
| MACD | -17.12 |
| 20-Day SMA | 904.00 |
Natco Pharma Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Natco Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Natco Pharma Ltd today is ₹858.20 on NSE and ₹858.20 on BSE.
- The 52-week high of Natco Pharma Ltd is ₹1,226.10, while the 52-week low is ₹789.30.
- The current market capitalisation of Natco Pharma Ltd is approximately ₹15,371 crore.
- The P/E (Price-to-Earnings) ratio of Natco Pharma Ltd is 10.97. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Natco Pharma Ltd is 1.97. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Natco Pharma Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Natco Pharma Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Natco Pharma Ltd has delivered a return of approximately -4.34%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Natco Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.42% promoters, 15.07% FIIs, 5.62% DIIs, and 23.41% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
